Lower rates of ART initiation and decreased retention among ART-naïve patients who consume alcohol enrolling in HIV care and treatment programs in Kenya and Uganda.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
09
2019
accepted:
01
10
2020
entrez:
23
10
2020
pubmed:
24
10
2020
medline:
18
12
2020
Statut:
epublish
Résumé
Almost 13 million people are estimated to be on antiretroviral therapy in Eastern and Southern Africa, and their disease course and program effectiveness could be significantly affected by the concurrent use of alcohol. Screening for alcohol use may be important to assess the prevalence of alcohol consumption and its impact on patient and programmatic outcomes. As part of this observational study, data on patient characteristics and alcohol consumption were collected on a cohort of 765 adult patients enrolling in HIV care in East Africa. Alcohol consumption was assessed with the AUDIT questionnaire at enrollment. Subjects were classified as consuming any alcohol (AUDIT score >0), hazardous drinkers (AUDIT score ≥8) and hyper drinkers (AUDIT score ≥16). The effects of alcohol consumption on retention in care, death and delays in antiretroviral therapy (ART) initiation were assessed through competing risk (Fine & Gray) models. Of all study participants, 41.6% consumed alcohol, 26.7% were classified as hazardous drinkers, and 16.0% as hyper drinkers. Depending on alcohol consumption classification, men were 3-4 times more likely to consume alcohol compared to women. Hazardous drinkers (median age 32.8 years) and hyper drinkers (32.7 years) were slightly older compared to non-hazardous drinkers (30.7 years) and non-hyper drinkers (30.8 years), (p-values = 0.014 and 0.053 respectively). Median CD4 at enrollment was 330 cells/μl and 16% were classified World Health Organization (WHO) stage 3 or 4. There was no association between alcohol consumption and CD4 count or WHO stage at enrollment. Alcohol consumption was associated with significantly lower probability of ART initiation (adjusted sub-distribution hazard ratio aSHR = 0.77 between alcohol consumers versus non-consumers; p-value = 0.008), and higher patient non-retention in care (aSHR = 1.77, p-value = 0.023). Alcohol consumption is associated with significant delays in ART initiation and reduced retention in care for patients enrolling in HIV care and treatment programs in East Africa. Consequently, interventions that target alcohol consumption may have a significant impact on the HIV care cascade.
Identifiants
pubmed: 33095784
doi: 10.1371/journal.pone.0240654
pii: PONE-D-19-24950
pmc: PMC7584184
doi:
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0240654Subventions
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069911
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Subst Abus. 2004 Mar;25(1):17-26
pubmed: 15201108
PLoS Med. 2012;9(7):e1001245
pubmed: 22802730
Lancet. 2009 Jan 3;373(9657):7-9
pubmed: 19038440
Drug Alcohol Depend. 2014 Jan 1;134:151-157
pubmed: 24169501
AIDS Behav. 2010 Aug;14(4):836-44
pubmed: 19015972
J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):194-9
pubmed: 17667330
PLoS One. 2011;6(7):e21797
pubmed: 21818265
Clin Infect Dis. 2007 Jun 1;44(11):1493-9
pubmed: 17479948
Alcohol Res Health. 2010;33(3):203-18
pubmed: 23584062
AIDS Care. 2015;27(1):54-8
pubmed: 25179410
Stat Med. 2017 Nov 30;36(27):4391-4400
pubmed: 28913837
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):455-61
pubmed: 22955054
Alcohol Res. 2015;37(2):287-97
pubmed: 26695751
AIDS Res Hum Retroviruses. 2011 Jul;27(7):751-8
pubmed: 21142607
Int J Public Health. 2010 Jun;55(3):159-66
pubmed: 19949966
Trop Med Int Health. 2010 Jun;15 Suppl 1:63-9
pubmed: 20586962
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):419-425
pubmed: 27243904
J Stud Alcohol. 2005 May;66(3):361-8
pubmed: 16047525
Int J Epidemiol. 2012 Oct;41(5):1256-64
pubmed: 21593078
Clin Infect Dis. 2016 Apr 1;62(7):935-944
pubmed: 26679625
Clin Infect Dis. 2009 Jan 15;48(2):248-56
pubmed: 19072715
AIDS Res Hum Retroviruses. 2010 May;26(5):511-8
pubmed: 20455765
Curr HIV/AIDS Rep. 2015 Dec;12(4):421-36
pubmed: 26412084